Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 51

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Survey of solution dynamics in Src kinase reveals allosteric cross talk between the ligand binding and regulatory sites

Tong, Michael, Pelton, Jeff G., Gill, Michelle L., Zhang, Weibing, Picart, Francis, Seeliger, Markus A. · 2017 · Nature Communications

Abstract

The catalytic domain of protein tyrosine kinases can interconvert between active and inactive conformations in response to regulatory inputs. We recently demonstrated that Src kinase features an allosteric network that couples substrate-binding sites. However, the extent of conformational and dynamic changes that are propagated throughout the kinase domain remains poorly understood. Here, we monitor by NMR the effect of conformationally selective inhibitors on kinase backbone dynamics. We find that inhibitor binding and activation loop autophosphorylation induces dynamic changes across the entire kinase. We identify a highly conserved amino acid, Gly449, that is necessary for Src activation. Finally, we show for the first time how the SH3–SH2 domains perturb the dynamics of the kinase domain in the context of the full length protein. We provide experimental support for long-range communication in Src kinase that leads to the relative stabilization of active or inactive conformations and modulation of substrate affinity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-02240-6

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 61

  1. Thomas, S. M. & Brugge, J. S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell. Dev. Biol. 13, 513–609 (1997). · DOI · Paper page
  2. Cohen, P. The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. Eur. J. Biochem. 268, 5001–5010 (2001). · DOI · Paper page
  3. Zhang, S. & Yu, D. Targeting Src family kinases in anti-cancer therapies: turning promise into triumph. Trends Pharmacol. Sci. 33, 122–128 (2012). · DOI · Paper page
  4. Xiao, Y. et al. Phosphorylation releases constraints to domain motion in ERK2. Proc. Natl Acad. Sci. USA 111, 2506–2511 (2014). · DOI · Paper page
  5. Kornev, A. P. & Taylor, S. S. Defining the conserved internal architecture of a protein kinase. Biochim. Et. Biophys. Acta (BBA)-Proteins Proteom. 1804, 440–444 (2010). · DOI · Paper page
  6. Xu, W., Doshi, A., Lei, M., Eck, M. J. & Harrison, S. C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3, 629–638 (1999). · DOI · Paper page
  7. Harrison, S. C. Variation on an Src-like theme. Cell 112, 737–740 (2003). · DOI · Paper page
  8. Cowan-Jacob, S. W. et al. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. Structure 13, 861–871 (2005). · DOI · Paper page
  9. Sun, G., Sharma, A. K. & Budde, R. J. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation. Oncogene 17, 1587–1595 (1998). · DOI
  10. Koshland, D. E. Jr, Nemethy, G. & Filmer, D. Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 5, 365–385 (1966). · DOI · Paper page
  11. Monod, J., Wyman, J. & Changeux, J. P. On the nature of allosteric transitions: a plausible model. J. Mol. Biol. 12, 88–118 (1965). · DOI · Paper page
  12. Changeux, J. P. 50 years of allosteric interactions: the twists and turns of the models. Nat. Rev. Mol. Cell Biol. 14, 819–829 (2013). · DOI · Paper page
  13. Cui, Q. & Karplus, M. Allostery and cooperativity revisited. Protein Sci. 17, 1295–1307 (2008). · DOI · Paper page
  14. Laine, E., Auclair, C. & Tchertanov, L. Allosteric communication across the native and mutated KIT receptor tyrosine kinase. PLoS Comput. Biol. 8, e1002661 (2012). · DOI
  15. Barkho, S. et al. Distal loop flexibility of a regulatory domain modulates dynamics and activity of C-terminal SRC kinase (csk). PLoS Comput. Biol. 9, e1003188 (2013). · DOI
  16. Foda, Z. H., Shan, Y., Kim, E. T., Shaw, D. E. & Seeliger, M. A. A dynamically coupled allosteric network underlies binding cooperativity in Src kinase. Nat. Commun. 6, 5939 (2015). · DOI · Paper page
  17. Masterson, L. R., Mascioni, A., Traaseth, N. J., Taylor, S. S. & Veglia, G. Allosteric cooperativity in protein kinase A. Proc. Natl Acad. Sci. USA 105, 506–511 (2008). · DOI · Paper page
  18. Meng, Y., Pond, M. P. & Roux, B. Tyrosine kinase activation and conformational flexibility: lessons from Src-family tyrosine kinases. Acc. Chem. Res. 50, 1193–1201 (2017). · DOI
  19. Fajer, M., Meng, Y. & Roux, B. The activation of c-Src tyrosine kinase: conformational transition pathway and free energy landscape. J. Phys. Chem. B 121, 3352–3363 (2017). · DOI
  20. Hari, S. B., Merritt, E. A. & Maly, D. J. Conformation-selective ATP-competitive inhibitors control regulatory interactions and noncatalytic functions of mitogen-activated protein kinases. Chem. Biol. 21, 628–635 (2014). · DOI
  21. Feldman, H. C. et al. Structural and functional analysis of the allosteric inhibition of IRE1alpha with ATP-competitive ligands. Acs. Chem. Biol. 11, 2195–2205 (2016). · DOI
  22. Popovych, N., Sun, S. J., Ebright, R. H. & Kalodimos, C. G. Dynamically driven protein allostery. Nat. Struct. Mol. Biol. 13, 831–838 (2006). · DOI · Paper page
  23. Manley, G. & Loria, J. P. NMR insights into protein allostery. Arch. Biochem. Biophys. 519, 223–231 (2012). · DOI
  24. Huse, M. & Kuriyan, J. The conformational plasticity of protein kinases. Cell 109, 275–282 (2002). · DOI · Paper page
  25. Tong, M. & Seeliger, M. A. Targeting conformational plasticity of protein kinases. Acs. Chem. Biol. 10, 190–200 (2015). · DOI
  26. Kwarcinski, F. E. et al. Conformation-selective analogues of dasatinib reveal insight into kinase inhibitor binding and selectivity. Acs. Chem. Biol. 11, 1296–1304 (2016). · DOI
  27. Getlik, M. et al. Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc. J. Med. Chem. 52, 3915–3926 (2009). · DOI
  28. Kleckner, I. R. & Foster, M. P. An introduction to NMR-based approaches for measuring protein dynamics. Biochim. Biophys. Acta 1814, 942–968 (2011). · DOI · Paper page
  29. Taylor, S. S., Keshwani, M. M., Steichen, J. M. & Kornev, A. P. Evolution of the eukaryotic protein kinases as dynamic molecular switches. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 2517–2528 (2012). · DOI · Paper page
  30. Gonfloni, S., Weijland, A., Kretzschmar, J. & Superti-Furga, G. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src. Nat. Struct. Biol. 7, 281–286 (2000). · DOI
  31. Berjanskii, M. V. & Wishart, D. S. The RCI server: rapid and accurate calculation of protein flexibility using chemical shifts. Nucleic Acids Res. 35, W531–W537 (2007). · DOI
  32. Van Durme, J. et al. A graphical interface for the FoldX forcefield. Bioinformatics 27, 1711–1712 (2011). · DOI · Paper page
  33. Xu, R., Liu, D. & Cowburn, D. Abl kinase constructs expressed in bacteria: facilitation of structural and functional studies including segmental labeling by expressed protein ligation. Mol. Biosyst. 8, 1878–1885 (2012). · DOI
  34. Liu, D., Yuan, Y., Xu, R. & Cowburn, D. Domain interactions of C-terminal Src Kinase determined through NMR spectroscopy with segmental isotope labeling. Protein Cell 8, 67–71 (2017). · doi:10.1007/s13238-016-0333-y
  35. Mao, H., Hart, S. A., Schink, A. & Pollok, B. A. Sortase-mediated protein ligation: a new method for protein engineering. J. Am. Chem. Soc. 126, 2670–2671 (2004). · DOI · Paper page
  36. Young, M. A., Gonfloni, S., Superti-Furga, G., Roux, B. & Kuriyan, J. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation. Cell 105, 115–126 (2001). · DOI · Paper page
  37. Leonard, S. E., Register, A. C., Krishnamurty, R., Brighty, G. J. & Maly, D. J. Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors. Acs. Chem. Biol. 9, 1894–1905 (2014). · DOI
  38. Tsutsui, Y., Deredge, D., Wintrode, P. L. & Hays, F. A. Imatinib binding to human c-Src is coupled to inter-domain allostery and suggests a novel kinase inhibition strategy. Sci. Rep. 6, 30832 (2016). · DOI
  39. Tanis, K. Q., Veach, D., Duewel, H. S., Bornmann, W. G. & Koleske, A. J. Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. Mol. Cell Biol. 23, 3884–3896 (2003). · DOI
  40. Seeliger, M. A. et al. c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. Structure 15, 299–311 (2007). · DOI · Paper page
  41. Wodicka, L. M. et al. Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem. Biol. 17, 1241–1249 (2010). · DOI
  42. Vajpai, N. et al. Solution conformations and dynamics of ABL kinase-inhibitor complexes determined by NMR substantiate the different binding modes of imatinib/nilotinib and dasatinib. J. Biol. Chem. 283, 18292–18302 (2008). · DOI · Paper page
  43. Laurini, E. et al. Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments. Mol. Oncol. 7, 968–975 (2013). · doi:10.1016/j.molonc.2013.06.001
  44. Soverini, S. et al. Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on chronic myeloid leukemia. Clin. Cancer Res. 12, 7374–7379 (2006). · DOI · Paper page
  45. Hari, S. B., Perera, B. G., Ranjitkar, P., Seeliger, M. A. & Maly, D. J. Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src. Acs. Chem. Biol. 8, 2734–2743 (2013). · DOI
  46. Krishnamurty, R. & Maly, D. J. Biochemical mechanisms of resistance to small-molecule protein kinase inhibitors. Acs. Chem. Biol. 5, 121–138 (2010). · DOI
  47. Georghiou, G., Kleiner, R. E., Pulkoski-Gross, M., Liu, D. R. & Seeliger, M. A. Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles. Nat. Chem. Biol. 8, 366–374 (2012). · DOI
  48. Stivers, J. T., Abeygunawardana, C. & Mildvan, A. S. 15N NMR relaxation studies of free and inhibitor-bound 4-oxalocrotonate tautomerase: backbone dynamics and entropy changes of an enzyme upon inhibitor binding. Biochemistry 35, 16036–16047 (1996). · DOI
  49. Ayrapetov, M. K. et al. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation. J. Biol. Chem. 281, 23776–23784 (2006). · DOI
  50. Bernado, P., Perez, Y., Svergun, D. I. & Pons, M. Structural characterization of the active and inactive states of Src kinase in solution by small-angle X-ray scattering. J. Mol. Biol. 376, 492–505 (2008). · DOI
  51. Skora, L., Mestan, J., Fabbro, D., Jahnke, W. & Grzesiek, S. NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors. Proc. Natl Acad. Sci. USA 110, E4437–E4445 (2013). · DOI
  52. Seeliger, M. A. et al. High yield bacterial expression of active c-Abl and c-Src tyrosine kinases. Protein Sci. 14, 3135–3139 (2005). · DOI · Paper page
  53. Nolen, B., Taylor, S. & Ghosh, G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol. Cell 15, 661–675 (2004). · DOI · Paper page
  54. Barker, S. C. et al. Characterization of pp60c-src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process. Biochemistry 34, 14843–14851 (1995). · DOI · Paper page
  55. Czisch, M. & Boelens, R. Sensitivity enhancement in the TROSY experiment. J. Magn. Reson. 134, 158–160 (1998). · DOI
  56. Pervushin, K. V., Wider, G. & Wüthrich, K. Single transition-to-single transition polarization transfer (ST2-PT) in [15N, 1H]-TROSY. J. Biomol. NMR 12, 345–348 (1998). · DOI · Paper page
  57. Meissner, A., Schulte-Herbrüggen, T., Briand, J. & Sørensen, O. W. Double spin-state-selective coherence transfer. Application for two-dimensional selection of multiplet components with long transverse relaxation times. Mol. Phys. 95, 1137–1142 (1998).
  58. Weigelt, J. Single scan sensitivity-and gradient-enhanced TROSY for multidimensional NMR experiments. J. Am. Chem. Soc. 120, 12706–12706 (1998). · DOI · Paper page
  59. Rance, M., Loria, J. P. & Palmer, A. G. Sensitivity improvement of transverse relaxation-optimized spectroscopy. J. Magn. Reson. 136, 92–101 (1999). · DOI · Paper page
  60. Zhu, G., Kong, X. M. & Sze, K. H. Gradient and sensitivity enhancement of 2D TROSY with water flip-back, 3D NOESY-TROSY and TOCSY-TROSY experiments. J. Biomol. NMR 13, 77–81 (1999). · DOI · Paper page
  61. Zhu, G., Xia, Y., Nicholson, L. K. & Sze, K. H. Protein dynamics measurements by TROSY-based NMR experiments. J. Magn. Reson. 143, 423–426 (2000). · DOI

Cited by

See all 51

Metadata

Authors
Tong, M., Pelton, J. G., Gill, M. L., Zhang, W., Picart, F., & Seeliger, M. A.
Venue
Nature Communications
Published
2017-12-18
Volume
8
Issue
1
ISSN
2041-1723
Cited by
51
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Survey of solution dynamics in Src kinase reveals allosteric cross talk between the ligand binding and regulatory sites. https://app.cochat.ai/papers/10.1038/s41467-017-02240-6
The paper
Tong, M., Pelton, J. G., Gill, M. L., Zhang, W., Picart, F., & Seeliger, M. A. (2017). Survey of solution dynamics in Src kinase reveals allosteric cross talk between the ligand binding and regulatory sites. Nature Communications. https://doi.org/10.1038/s41467-017-02240-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.